GELO, Ilaria
 Distribuzione geografica
Continente #
NA - Nord America 400
EU - Europa 209
AS - Asia 136
SA - Sud America 3
OC - Oceania 1
Totale 749
Nazione #
US - Stati Uniti d'America 400
CN - Cina 78
IT - Italia 71
UA - Ucraina 69
SG - Singapore 42
DE - Germania 41
HK - Hong Kong 7
FR - Francia 6
GB - Regno Unito 6
BE - Belgio 5
FI - Finlandia 4
KR - Corea 3
SE - Svezia 3
BR - Brasile 2
IN - India 2
TR - Turchia 2
AE - Emirati Arabi Uniti 1
AU - Australia 1
CZ - Repubblica Ceca 1
FK - Isole Falkland (Malvinas) 1
LU - Lussemburgo 1
MY - Malesia 1
PL - Polonia 1
RO - Romania 1
Totale 749
Città #
Chandler 133
Jacksonville 49
Singapore 32
Princeton 28
Dearborn 26
Sassari 26
New York 24
Nanjing 19
Wilmington 16
Boardman 13
Beijing 12
Munich 12
Woodbridge 10
Agrigento 9
Alghero 6
Changsha 6
Hong Kong 6
Nanchang 6
Brussels 5
Jiaxing 5
Ann Arbor 4
Città Di Castello 4
Hebei 4
Helsinki 4
Kunming 4
Selargius 4
Jinan 3
Seoul 3
Shenyang 3
Tianjin 3
Torino 3
Bari 2
Fairfield 2
Guangzhou 2
Hangzhou 2
São Paulo 2
West Jordan 2
Ashburn 1
Bologna 1
Brno 1
Dallas 1
Dubai 1
Edinburgh 1
Frankfurt am Main 1
Horia 1
Izmir 1
Kuala Lumpur 1
Lamézia 1
Lanzhou 1
London 1
Luxembourg 1
Melbourne 1
New Delhi 1
Nuremberg 1
Padova 1
Pune 1
Reston 1
San Francisco 1
Santa Clara 1
Seattle 1
Shenzhen 1
Vigasio 1
Warsaw 1
Zhengzhou 1
Totale 521
Nome #
The role of molecular breast imaging in predicting complete tumor response to treatment and residual tumor extent following neoadjuvant therapy 69
131I-SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinomas (DTC) in long-term follow-up 69
131I-SPECT/CT in differentiating neck iodine fixing foci in patients with differentiated thyroid carcinoma (DTC). 63
131I SPECT/CT in neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC). 59
Breast-specific imaging (BSGI) in predicting tumor response to treatment and in assessing residual tumor size following neoadjuvant therapy in locally advanced primary breast cancer. 57
Neck lymph node metastases in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a diagnostic 131I-SPECT/CT study 57
Role of Diagnostic (131)I SPECT/CT in Long-Term Follow-up of Patients with Papillary Thyroid Microcarcinoma. 54
Breast scintigraphy with brest specific gammacamera (BSGC) and dynamic contrast enhanced magnetic resonance imaging (DCE-MRI ) in local staging and tumor size assessment of primary breast cancer. 54
131I-SPECT/CT in the diagnosis and characterization of metastatic lesions in patients with differentiated thyroid carcinoma (DTC) in chronic follow-up 52
Neck iodine fixing foci in differentiated thyroid carcinoma (DTC) follow-up patients: a 131 I-SPECT/CT study. 49
A diagnostic 131I-SPECT/CT study in patients in follow up for papillary thyroid microcarcinoma.( PTMC) 47
131I-SPECT/CT usefulness in the follow up of patients thyroidectomized for thyroid papillary microcarcinoma ( PTMC). 47
Neck lymph node metastasis detection in patients with differentiated thyroid carcinoma (DTC) in long-term follow-up: a 131I-SPECT/CT study. 44
The diagnostic usefulness of131i-spect/ct at both radioiodine ablation and during long-term follow-up in patients thyroidectomized for differentiated thyroid carcinoma: Analysis of tissue risk factors ascertained at surgery and correlated with metastasis appearance 39
131I-SPECT/CT at the first radioiodine ablation and during follow-up in patients with differentiated thyroid carcinoma (DTC). 21
Totale 781
Categoria #
all - tutte 4.092
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 4.092


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020104 0 0 0 0 18 21 23 3 14 10 13 2
2020/202191 13 0 19 3 15 2 13 0 13 13 0 0
2021/202281 7 1 6 0 7 1 6 5 5 3 12 28
2022/2023223 14 28 1 54 12 37 2 23 38 5 6 3
2023/202490 13 10 2 4 33 2 0 1 0 2 8 15
2024/202574 1 12 25 18 18 0 0 0 0 0 0 0
Totale 781